2021 NCI Director's Intramural Innovation Awards
, by DCEG Staff
The NCI Director’s Intramural Innovation Award Program is designed to support development of highly innovative approaches and technology aimed at significant cancer–related problems. Winning proposals showed potential for significant scientific or public health impact, as well as approach, innovation, and programmatic relevance to the mission of the Division. Recipients will use their awards in fiscal year 2021.
Principal Investigator Award Winners
Jiyeon Choi, Ph.D., M.S. – “Single-cell eQTL profiling of normal lung in Asian never-smokers for functional characterization of lung cancer risk-associated genomic loci”
M. Constanza Camargo, Ph.D. – “Parasite serological profiling of patients with advanced gastric preneoplastic lesions”
Career Development Award Winners
Jongeun Rhee, Sc.D. – “Serum levels of per- and polyfluoroalkyl substances (PFAS) and thyroid cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial”
Katelyn Connelly, Ph.D. – “Examining the interplay between PDAC risk loci and cellular stress responses”
Minkyo Song, M.D., Ph.D. – “Autoantibody Immunoproteomic Microarray for Cancer-Associated Autoimmune Diseases”
Monica D'Arcy, Ph.D. – “A network analysis approach to understanding never-smoking lung cancer risk factors”
Rohit Thakur, Ph.D. – “Spatial fine mapping of ultraviolet radiation-responsive melanoma susceptibility and pigmentation loci”